Negative regulation of triglyceride biosynthetic process

pathway activity — cross-omics
GO:0010868Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of triglyceride biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the PDAC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are FAM124A, PLS3, and XG, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of triglyceride biosynthetic process activity versus FAM124A in PDAC (Pearson r = 0.16).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
PDACFAM124A →+0.323+0.152<.001.00234
BRCAPLS3 →-0.806-0.748<.001<.00134
BRCAXG →-0.618-0.703.006.00133
BRCAZNF273 →-0.575-0.672<.001.00133
LUADRNU6-1233P →-0.574-0.124.009.00233
OVRPL26P29 →+0.330+0.251.003.00633
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0010868 vs FAM124A — PDAC

Per-sample scatter of Negative regulation of triglyceride biosynthetic process activity vs FAM124A in PDAC.

Explore this scatter interactively →

Exploration